Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas.
Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.
Acquired Demyelinating and Other Autoimmune Disorders of the Central Nervous System in Children.
Combined central and peripheral demyelination: A case description.
Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia.
Diffusion MRI abnormalities detection with orientation distribution functions: A multiple sclerosis longitudinal study.
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
The Roles of Vitamin D and Its Analogs in Inflammatory Diseases.
Discovering Gene Regulatory Elements Using Coverage-based Heuristics.
Frequent laboratory abnormalities in CIDP patients.
Use of Cannabinoids for Spasticity and Pain Management in MS.
Expression of DNA methylation genes in secondary progressive multiple sclerosis.
Quality of life in patients with multiple sclerosis in Republic of Srpska.
The perceptions of people with multiple sclerosis about the NHS provision of physiotherapy services.
Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5.
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Tumefactive multiple sclerosis in taiwan.
Eicosapentaenoic acid pre-treatment reduces biochemical changes induced in total brain and myelin of weanling Wistar rats by cuprizone feeding.
Attributional style and depression in multiple sclerosis: the learned helplessness model.
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Neuro-nutraceuticals: Further insights into their promise for brain health.
Efficacy of Tryptophan Immunoadsorption Plasmapheresis for Neuromyelitis Optica in Two Cases.
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation.
Pages
« first
‹ previous
…
561
562
563
564
565
566
567
568
569
…
next ›
last »